Adagio Medical Inc

ADGM

Latest QuantConomy context for ADGM: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.

Asset class

stock

Primary venue

NASDAQ

Recent signals

SEC filings

Asset profile

QuantConomy has a structured record for ADGM. More descriptive asset metadata will appear here when the platform record includes it.

Latest signal rows

Recent signals for ADGM

Scored rows are pulled from the same signal API used by the digests.

Signal	Direction	Score	Observed	Reason
earnings earnings release	neutral	40	May 12, 12:00 AM	ADGM filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-05-12. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read).
corporate event delisting	very bearish	75	Jun 12, 08:50 PM	ADGM filed 8-K: Delisting Notice - 1 material event - [strong very bearish signal]
corporate event other event	neutral	70	May 21, 08:35 PM	ADGM filed 8-K: Other Events - 1 material event - [strong neutral signal]

EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).

Market	Exchange	Source	Asset record
ADGM	NASDAQ	fmp	Adagio Medical Holdings, Inc.
ADGM	NASDAQ	alpaca	Adagio Medical Holdings, Inc Common Stock
ADGM	NASDAQ	alphavantage	Adagio Medical Holdings Inc

Buys, last 90d

Sells, last 90d

Rows

Date	Insider	Role	Type	Shares	Price	Value	Filing
Mar 6, 2026	Kaster Deborah	Chief Financial Officer	grant	490,500	—	—	4 on EDGAR
Mar 6, 2026	Usen Todd	Chief Executive Officer	grant	800,000	—	—	4 on EDGAR
Dec 11, 2025	Salmon Sean	Insider	grant	90,000	—	—	4 on EDGAR

Source: SEC filings via QuantConomy. Not investment advice.

Get the data

These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.